Godavari Biorefineries shares: Small-cap stock jumps 15% on US patent grant; trading volumes surge. Do you own?
60-Word AI Digest
Godavari Biorefineries shares rose as much as 14.8% after the company said a US patent for compounds intended to treat cancer had been granted. Trading volume surged to more than 132 times its weekly average. The patent’s commercial potential and financial contribution remain unclear.
Key Takeaways
- Godavari Biorefineries shares rose as much as 14.8% after the company said a US patent for compounds intended to treat cancer had been granted.
- Trading volume surged to more than 132 times its weekly average.
- The patent’s commercial potential and financial contribution remain unclear.
Godavari Biorefineries shares rose as much as 14.8% after the company said a US patent for compounds intended to treat cancer had been granted. Trading volume surged to more than 132 times its weekly average. The patent’s commercial potential and financial contribution remain unclear.
Original Publisher Attribution
This summary was curated from Livemint.